This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Information on how to access Enbrel® (etanercept) prescribing information and adverse event reporting can be found at the bottom of the page.

Commitment to inflammation care

Transforming lives for >20 years

Anti-TNF agents, including Enbrel, have revolutionised the treatment of chronic inflammatory diseases.1 Pfizer is committed to using our extensive experience and expertise to continue to support and transform the lives of patients living with these debilitating diseases. 

Enbrel has extensive clinical experience across a range of inflammatory diseases2,3

  • Enbrel was the first approved anti-TNF agent for rheumatoid arthritis and is now approved to treat six additional inflammatory conditions:2,4-7
  • Enbrel has over 7 million patient-years exposure across all indications3
  • To date, there have been more than 450 trials conducted with Enbrel and over 7,000 publications


Confidence of quality

Anti-TNF agents, including Enbrel, have revolutionised the treatment of chronic inflammatory diseases.1 Pfizer is committed to using our extensive experience and expertise to continue to support and transform the lives of patients living with these debilitating diseases.

  1. The manufacture of original biologics and biosimilars is challenging. Pfizer has over 20 years’ experience manufacturing Enbrel, and fully understands the complex processes involved
  2. At the Grange Castle facility where Enbrel is manufactured, Pfizer has amassed extensive expertise in controlling production lines to ensure the consistent delivery of a high quality biologic. To ensure quality:
    1. Enbrel has been subject to 19 manufacturing improvements since 19988
    2. 20,000 hours of maintenance are performed annually on the equipment used to produce Enbrel8
  3. Every batch of Enbrel:
    1. Takes 43 days to create8
    2. Undergoes >20 testing procedures and 100s of quality control checks8
    3. Is produced in state-of-the-art facilities8

Pfizer’s commitment and dedication ensures the manufacture of a high quality biologic for your patients.

A valuable partner to patients and the NHS

Anti-TNF agents, including Enbrel, have revolutionised the treatment of chronic inflammatory diseases.1 Pfizer is committed to using our extensive experience and expertise to continue to support and transform the lives of patients living with these debilitating diseases.

  1. Pfizer is committed to being a trusted partner for healthcare professionals and centres, helping to shape the future of inflammation care. We are also committed to making a difference to the lives of patients across the UK
  2. Pfizer is dedicated to delivering cost-effective and patient-centered care; funding home delivery and patient services to complement and enhance patient care
    1. The Together online support programme  was developed in collaboration with Enbrel users. It gives patients content tailored to their condition, administration method and length of time they've been taking Enbrel
  3. Pfizer aims to provide value for patients, clinicians and commissioners
    1. Physicians and those with inflammatory conditions will continue to have access to a medicine they know and trust in a new and changing environment

Explore more

Enbrel dosing and administration

Learn more about the dosing and administration of Enbrel, across indications.

MyClic administration

Enbrel patient support

See what online support your patients have access to

Find out more

References:
  1. Vincent FB et al. Ann Rheum Dis. 2013;72:165-178.
  2. Enbrel (etanercept) SmPC. Available at http://www.medicines.org.uk/emc [Accessed March 2021].
  3. Etanercept PSUR 27. February 2020
  4. Humira (adalimumab) SmPC.
  5. Remicade (infliximab) SmPC.
  6. Cimzia (certolizumab pegol) SmPC.
  7. Simponi (golimumab) SmPC.
  8. Data on file. New York, NY Pfizer Inc.
PP-ENB-GBR-0983. June 2021

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No